RiconPharma provides R&D Services such as Pre-formulation Studies, Formulation, Technology, Manufacturing, Analytical Development, and Regulatory Submissions to Pharma, Specialty, and Marketing Companies.

RiconPharma's Strategy involves developing new formulations for 505 (b)(2) submissions through licensing, partnerships, alliances, and joint ventures with Pharma, Specialty, and Marketing Companies.

Product Enhancements, Product Life Cycle Planning, Line Extensions, Technology Development, Patents, and IP are RiconPharma's Key Focus Areas.

RiconPharma's business relies on developmental and licensing fees, milestone payments, royalties, and product partnerships.